Type 2 diabetes raises serum sclerostin levels and disturbs the relation between sclerostin and bone mineral density: a call for caution with antisclerostin therapy in osteoporosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-3235
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Type 2 diabetes raises serum sclerostin levels and disturbs the relation between sclerostin and bone mineral density: a call for caution with antisclerostin therapy in osteoporosis ; volume:41 ; number:1 ; day:4 ; month:3 ; year:2014 ; pages:37-43 ; date:1.2014
Egyptian rheumatology & rehabilitation ; 41, Heft 1 (4.3.2014), 37-43, 1.2014
- Urheber
-
Al-Zifzaf, Dina S.
Hamza, Sarah A.
Kaddah, Eman A.
Abo-Shady, Rania A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.4103/1110-161X.128136
- URN
-
urn:nbn:de:101:1-2020102120353730743901
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Al-Zifzaf, Dina S.
- Hamza, Sarah A.
- Kaddah, Eman A.
- Abo-Shady, Rania A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sclerostin Inhibition in the Management of Osteoporosis
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Sclerostin and Cardiovascular Disease
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
Copeptin und Sclerostin in schwangerschaftsassoziierten Erkrankungen
IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Serum sclerostin levels in osteoporotic fracture patients
Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
Relation between serum sclerostin and CTRP3 levels and bone mineral density in diabetic postmenopausal women
Association of serum sclerostin levels with marrow adiposity in postmenopausal women with glucocorticoid-induced osteoporosis
Strukturelle und funktionelle Charakterisierung des Knochenwachstums-Modulators Sclerostin
Sclerostin Inhibition in the Management of Osteoporosis
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Sclerostin and Cardiovascular Disease
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
Copeptin und Sclerostin in schwangerschaftsassoziierten Erkrankungen
IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Serum sclerostin levels in osteoporotic fracture patients
Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
Relation between serum sclerostin and CTRP3 levels and bone mineral density in diabetic postmenopausal women
Association of serum sclerostin levels with marrow adiposity in postmenopausal women with glucocorticoid-induced osteoporosis
Strukturelle und funktionelle Charakterisierung des Knochenwachstums-Modulators Sclerostin
Sclerostin Inhibition in the Management of Osteoporosis
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Sclerostin and Cardiovascular Disease
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
Copeptin und Sclerostin in schwangerschaftsassoziierten Erkrankungen
IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Serum sclerostin levels in osteoporotic fracture patients
Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
Relation between serum sclerostin and CTRP3 levels and bone mineral density in diabetic postmenopausal women
Association of serum sclerostin levels with marrow adiposity in postmenopausal women with glucocorticoid-induced osteoporosis